year of study: 1987
CONCENSUS trial group
ACE inhibitor enalapril was compared with placebo in patients with severe heart failure
enalapril reduces the conversion of angiotensin I to angiotensin II
small trial of 253 patients
primary endpoint of death reduced from 44% to 26% p = 0.0001